استشهادات التسجيلة

توثيق جمعية علم النفس الأمريكية APA (الطبعة السابعة)
Cheneau, C., Barthier, S., Lemonnier, J., Andre, F., Dubot, C., Teixeira, L., . . . Marques, S. (2022). Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: Study design of PADA-1. BMJ Publishing Group.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)
Cheneau, C., et al. Randomised, Open-label, Multicentric Phase III Trial to Evaluate the Safety and Efficacy of Palbociclib in Combination with Endocrine Therapy, Guided by ESR1 Mutation Monitoring in Oestrogen Receptor-positive, HER2-negative Metastatic Breast Cancer Patients: Study Design of PADA-1. BMJ Publishing Group, 2022.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)
Cheneau, C., et al. Randomised, Open-label, Multicentric Phase III Trial to Evaluate the Safety and Efficacy of Palbociclib in Combination with Endocrine Therapy, Guided by ESR1 Mutation Monitoring in Oestrogen Receptor-positive, HER2-negative Metastatic Breast Cancer Patients: Study Design of PADA-1. BMJ Publishing Group, 2022.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.